HemaSphere
(Aug 2023)
PB2562: STUDY DESIGN OF THE AURORA TRIAL: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA
- Cynthia Levy,
- Karl E. Anderson,
- Manisha Balwani,
- Herbert L. Bonkovsky,
- Amy Dickey,
- Siobán Keel,
- Brendan Mcguire,
- Roy Smith,
- Manish Thapar,
- Bruce Wang,
- William Savage
Affiliations
- Cynthia Levy
- 1 University of Miami Miller School of Medicine
- Karl E. Anderson
- 2 University of Texas Medical Branch
- Manisha Balwani
- 3 Icahn School of Medicine at Mount Sinai
- Herbert L. Bonkovsky
- 4 Walk Forest University School of Medicine
- Amy Dickey
- 5 Harvard Medical School and Massachusetts General Hospital
- Siobán Keel
- 6 University of Washington
- Brendan Mcguire
- 7 University of Alabama at Birmingham
- Roy Smith
- 8 University of Pittsburgh School of Medicine
- Manish Thapar
- 9
- Bruce Wang
- 11 University of California San Francisco Porphyria Center
- William Savage
- 12 Disc Medicine
- DOI
-
https://doi.org/10.1097/01.HS9.0000976940.90434.6e
- Journal volume & issue
-
Vol. 7
p.
e904346e
WeChat QR code